Bellevue Group AG

SEC CIK: 0001674546
Latest filing: Aug 14, 2026

SEC filings (opens in a new tab)

CRNX holding history

Crinetics Pharmaceuticals, Inc. in every 13F filed by Bellevue Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CRNX overview All 13F holders of CRNX Full Q2 2026 holdings

Shares (Q2 2026): 2,620,000
Value: $98.0M
% of portfolio: 2.1%
Quarters held: 3; Since Q4 2025

Holdings of CRNX by Bellevue Group AG, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	2,620,000	$98.0M	2.1%	−660,000−20.1%	Reduced	Holders
Q1 2026	3,280,000	$119.1M	2.8%	+3,275,960+81,088.1%	Added	Holders
Q4 2025	4,040	$188.1K	<0.1%	+4,040	New	Holders